<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>10652927286493</udiDi>
    <basicUdiDi>B-10652927286493</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280040B0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:26:24.623Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286417</udiDi>
    <basicUdiDi>B-10652927286417</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280036B1P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:26:05.326Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286370</udiDi>
    <basicUdiDi>B-10652927286370</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10652927286370</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:26:03.629Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927286325</udiDi>
    <basicUdiDi>B-10652927286325</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280026B0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:26:02.826Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927285878</udiDi>
    <basicUdiDi>B-10652927285878</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO272026F4P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:26:02.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927285830</udiDi>
    <basicUdiDi>B-10652927285830</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO272026B0P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:25:58.021Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927285816</udiDi>
    <basicUdiDi>B-10652927285816</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO270136B0P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:25:57.218Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927285779</udiDi>
    <basicUdiDi>B-10652927285779</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO270036B0P</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:25:56.436Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927262213</udiDi>
    <basicUdiDi>B-10652927262213</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO184019F4P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:20:01.020Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927262169</udiDi>
    <basicUdiDi>B-10652927262169</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO185019F4P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:19:58.615Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927259695</udiDi>
    <basicUdiDi>B-10652927259695</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO272024F13M</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:19:42.601Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927249993</udiDi>
    <basicUdiDi>B-10652927249993</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO184016F4P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:17:44.018Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927244882</udiDi>
    <basicUdiDi>B-10652927244882</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO186016F13M</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:17:24.813Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927227366</udiDi>
    <basicUdiDi>B-10652927227366</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO272060A4P</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:14:41.332Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927217176</udiDi>
    <basicUdiDi>B-10652927217176</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO272036B0P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:10:06.100Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927211433</udiDi>
    <basicUdiDi>B-10652927211433</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO280030B0P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:07:50.727Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927207283</udiDi>
    <basicUdiDi>B-10652927207283</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO175019F13M</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:06:34.643Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927205098</udiDi>
    <basicUdiDi>B-10652927205098</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO273017B0P</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:05:36.153Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927200987</udiDi>
    <basicUdiDi>B-10652927200987</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO176013F13M</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:04:42.455Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927199038</udiDi>
    <basicUdiDi>B-10652927199038</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO175016F4P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-08-04T14:01:01.644Z</lastUpdated>
  </row>
</eudamedExport>